Naropin Injection

Signal word

DANGER. GHS Class: Respiratory sensitisation. Category 1. Skin Sensitization. Category 1.

Hazard statements

May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause an allergic skin reaction.

Precautionary statements

Avoid breathing dust/fume/gas/mist/vapours/spray. Contaminated work clothing should not be allowed out of the workplace. Wear protective gloves/protective clothing/eye protection/face protection. In case of inadequate ventilation wear respiratory protection. IF ON SKIN: Wash with plenty of water. IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. Specific treatment (see ... on this label). If skin irritation or rash occurs: Get medical advice/attention. If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. Take off contaminated clothing and wash it before reuse. Dispose of contents/container in accordance with Local, State, Federal and Provincial regulations. Emergency Overview: This product is intended for therapeutic use only when prescribed by a physician. Potential adverse reactions from prescribed doses and overdoses are described in the package insert.

Principle Routes of Exposure

Inhalation Ingestion Eye contact Skin Absorption. Injection.

Potential health effects

Eye: Contact with eyes may cause irritation. Signs/Symptoms: Possible adverse reactions include: hypotension, nausea, vomiting, bradycardia, headache, paresthesia, back pain, pain, pruritus, fever, dizziness, rigors, hypoesthesia, urinary retention, anxiety, breast disorders, and rhinitis. Occupational exposure has not been fully investigated. Aggravation of Pre-Existing

Medical Conditions Generally Aggravated by Exposure

Accidental Exposure Individuals with a known hypersensitivity to Conditions: ropivacaine or to any local anesthetic agent of the amide type.